| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/10/2011 | US20110034454 Morpholino pyrimidine derivatives and their use in therapy |
| 02/10/2011 | US20110034443 Uses of substituted imidazoheterocycles |
| 02/10/2011 | US20110034397 Intestinal immune system stimulator |
| 02/10/2011 | US20110034396 Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110033884 PD-1, A Receptor for B7-4, and Uses Therefor |
| 02/10/2011 | US20110033551 Nucleic acid microspheres, production and delivery thereof |
| 02/10/2011 | US20110033527 Opthalmic compositions of cyclosporin |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033501 Recombinant bacterium capable of eliciting an immune response against enteric pathogens |
| 02/10/2011 | US20110033500 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb-neisseria meningitidis |
| 02/10/2011 | US20110033499 Anti-viral nutraceutical |
| 02/10/2011 | US20110033493 Vaccine |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033485 Analogues of glycolipids useful as immunoadjuvants |
| 02/10/2011 | US20110033484 LprG AS A CHAPERONE OF IMMUNE ADJUVANTS |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033478 Canine thymic stromal lymphopoietin protein and uses thereof |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033450 Antibody Against Anthrax Toxins |
| 02/10/2011 | US20110033449 Human immune therapies using a CD27 agonist alone or in combination with other immune modulators |
| 02/10/2011 | US20110033416 RNA Vaccines |
| 02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | CA2806840A1 Method for in vivo expansion of t regulatory cells |
| 02/10/2011 | CA2768858A1 Bicyclic aryl sphingosine 1-phosphate analogs |
| 02/10/2011 | CA2768195A1 Lipidated oxoadenine derivatives |
| 02/09/2011 | EP2281871A1 Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281840A2 Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281574A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
| 02/09/2011 | EP2281561A2 Use of LCK inhibitors for treatment of immunologic diseases |
| 02/09/2011 | EP2281032A1 Compositions for treating an arthritic condition |
| 02/09/2011 | EP2281031A2 Methods and compositions for accelerating the generation of regulatory tcells ex vivo |
| 02/09/2011 | EP2280996A2 AFFINITY MATURED CRIg VARIANTS |
| 02/09/2011 | EP2280987A2 Triterpene saponins, methods of synthesis, and uses thereof |
| 02/09/2011 | EP2280986A2 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/09/2011 | EP2280946A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 02/09/2011 | EP2280766A1 Carboxamide compounds and their use as chemokine receptor agonists |
| 02/09/2011 | EP1765395B1 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| 02/09/2011 | EP1689715B1 Tubulin inhibitors |
| 02/09/2011 | EP1451192B1 Novel crystalline compound |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | EP1011686B9 Modulation of human mast cell activation |
| 02/09/2011 | CN101970666A Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 02/09/2011 | CN101970496A Antibody against the csf-1 r |
| 02/09/2011 | CN101970493A A monoclonal antibody and a method thereof |
| 02/09/2011 | CN101970442A Bicyclic pyrrole compound |
| 02/09/2011 | CN101970430A Novel pyrimidine derivatives |
| 02/09/2011 | CN101970420A Oxadiazole derivatives |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970411A (e) -n -(2-amino-phenyl) -3-{1-[4-(1-methyl-1h-pyrazol-4-yl)- benzenesulfonyl]-1h-pyrrol-3-yl} -acrylamide salts |
| 02/09/2011 | CN101970052A Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 02/09/2011 | CN101970005A Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 02/09/2011 | CN101969980A Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 02/09/2011 | CN101969966A Bifidobacterium for dust mite allergy |
| 02/09/2011 | CN101969945A Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/09/2011 | CN101967442A Barley monascus prepared wine and preparation method thereof |
| 02/09/2011 | CN101967205A Beta-dextriferron composite and preparation method thereof |
| 02/09/2011 | CN101967196A Interferon fusion protein, preparation thereof and application thereof |
| 02/09/2011 | CN101967193A Hsp60 fragment capable of being combined with LOX-1, derivatives thereof and use thereof |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967143A Ligands for G-protein coupled receptors |
| 02/09/2011 | CN101967113A 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof |
| 02/09/2011 | CN101967094A Phenylacetyl quinic acid of witlooves and ester compound thereof |
| 02/09/2011 | CN101966326A Health-care product for improving human immunity |
| 02/09/2011 | CN101966311A Chinese medicinal preparation for treating lupus erythematosus |
| 02/09/2011 | CN101966292A Sugarless Chinese medicinal oral liquid and preparation method thereof |
| 02/09/2011 | CN101966276A Soup for nourishing yin and restraining excessive yin and preparation method and application thereof |
| 02/09/2011 | CN101966253A Tao hong si wu granule and preparation method thereof |
| 02/09/2011 | CN101966224A Method for producing astragalus and codonopsis pilosula compound extract |
| 02/09/2011 | CN101966223A Fingerprint detection method for compound wintercreeper preparation |
| 02/09/2011 | CN101966199A Application of campanumoea polysaccharide in preparation of medicament and health care food |
| 02/09/2011 | CN101966195A Application of quercetin in preparing medicaments for treating organ transplant rejection reactions |
| 02/09/2011 | CN101966180A Polymorph of a pharmaceutical |
| 02/09/2011 | CN101966169A Compound immunopotentiator for sea cucumber and preparation method thereof |
| 02/09/2011 | CN101966165A Solid effervescent mixture for the oral absorption |
| 02/09/2011 | CN101966148A Injection composition comprising coenzyme Q10 and preparation method thereof |
| 02/09/2011 | CN101966145A 2-amino-2-(2-[4-octyl phenyl]ethyl)-1,3-propanediol hydrochloride preparation and preparation method thereof |
| 02/09/2011 | CN101966144A Preparation and application of olopatadine in-situ gel |
| 02/09/2011 | CN101647890B Compound calamine lotion and preparation method thereof |
| 02/09/2011 | CN101647888B Drug for external use for dispelling wind and arresting itching and preparation method thereof |
| 02/09/2011 | CN101584803B Medicament for improving immunizing power and preparing method thereof |
| 02/09/2011 | CN101485820B Health-care bolus for persons in middle and old age |
| 02/09/2011 | CN101455738B Traditional Chinese medicine composition for treating eczema and preparation method thereof |
| 02/09/2011 | CN101422500B Immunoenhancement regulator of pig blue-ear disease vaccine and use thereof |
| 02/09/2011 | CN101272793B Sphingomyelin-containing medicine, food and drink or fodder |
| 02/09/2011 | CN101259262B Inhalation for improving immunity and preparation thereof |
| 02/09/2011 | CN101181315B New purpose of Yulangsan polysaccharide |
| 02/09/2011 | CN101128122B Fermented tea beverage and tea beverage |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |